Wednesday, March 20, 2013

[Health] High-dose statins 'raise risk of serious kidney problems'

High-dose statins 'raise risk of serious kidney problems'
http://www.telegraph.co.uk/health/healthnews/9941391/High-dose-statins-raise-risk-of-serious-kidney-problems.html
Taking strong doses of simvastatin, atorvastatin or rosuvastatin increases the risk of being hospitalised with a condition called acute kidney injury, or AKI, by 34 per cent on average, found the Canadian team.

Melanoma Drug Succeeds in Late-Stage Trial
http://www.counselheal.com/articles/4448/20130320/amgen-shows-strong-results-melanoma-treatment-eno.htm
Melanoma Drug Succeeds in Late-Stage Trial. By ANDREW POLLACK. Published: March 19, 2013. A cancer drug based on a tumor-killing virus has for the first time succeeded in a late-stage clinical trial, giving a lift to a technology that has long tantalized ...

Douglas County named one of least healthiest in Oregon
http://www.unionvilletimes.com/?p=14553
ROSEBURG (KMTR) - Douglas County is ranked as one of the least healthy counties in Oregon, according to the 2013 National County Health Rankings.

Blood Test Implant: Tiny Under-Skin Device Sends Instant Lab Analysis To Your ...
http://www.dailymail.co.uk/sciencetech/article-2296347/The-medical-lab-skin-automatically-phone-doctor-fall-ill.html
Forget the pricks and pains of needles; blood testing may have just gotten a whole lot easier. Swiss researchers unveiled a prototype for a blood-testing device that lives under the skin during the annual Design, Automation and Test in Europe conference on ...

FDA advisers vote for approval of Abbott's implantable heart device
http://www.ptca.org/news/2013/0320_ABBOTT_MITRACLIP.html
Wed Mar 20, 2013 9:14pm EDT. (Reuters) - A slim majority of advisers to the U.S. Food and Drug Administration voted on Wednesday for approval of Abbott Laboratories' implantable heart device MitraClip, saying it had more benefits than risks.

No comments:

Post a Comment